JNK1/2/3 Polyclonal antibody
JNK1/2/3 Polyclonal Antibody for IF, IP, WB, ELISA
Host / Isotype
Rabbit / IgG
human, mouse, rat, monkey and More (1)
WB, IP, IHC, IF, ELISA
Cat no : 51153-1-AP
Validation Data Gallery
|Positive WB detected in||HeLa cells, A549 cells, COS-7 cells, NIH/3T3 cells|
|Positive IP detected in||HeLa cells|
|Positive IF detected in||HeLa cells, HUVEC cells|
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunoprecipitation (IP)||IP : 0.5-4.0 ug for IP and 1:500-1:2000 for WB|
|Immunofluorescence (IF)||IF : 1:10-1:100|
|Sample-dependent, check data in validation data gallery|
The immunogen of 51153-1-AP is JNK1/2/3 Fusion Protein expressed in E. coli.
|Tested Reactivity||human, mouse, rat, monkey|
|Cited Reactivity||human, mouse, rat, rabbit|
|Host / Isotype||Rabbit / IgG|
|Immunogen||JNK1/2/3 fusion protein Ag1442|
|Full Name||mitogen-activated protein kinase 9|
|Calculated molecular weight||424 aa, 48 kDa|
|Observed molecular weight||44-55 kDa|
|GenBank accession number||BC032539|
|Gene ID (NCBI)||5601|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.|
c-Jun N-terminal kinases (JNKs), first characterized as stress-activated members of the mitogen-activated protein kinase (MAPK) family, have shown their critical roles in the development of a number of cellular progress and diseases, including proliferation, embryonic development, apoptosis, diabetes, neurodegeneration and liver disease (PMID: 19900593). JNK1, JNK2, JNK3 also name as MAPK8, MAPK9, MAPK10, JNK1 and JNK2 are ubiquitously expressed, but JNK3 is expressed primarily in the brain (PMID: 27698029). This antibody can recognize JNK1, JNK2 and JNK3, we get bands around 44-55 kDa.
|Product Specific Protocols|
|WB protocol for JNK1/2/3 antibody 51153-1-AP||Download protocol|
|IF protocol for JNK1/2/3 antibody 51153-1-AP||Download protocol|
|IP protocol for JNK1/2/3 antibody 51153-1-AP||Download protocol|
|Click here to view our Standard Protocols|
m6 A Reader YTHDF1-Targeting Engineered Small Extracellular Vesicles for Gastric Cancer Therapy via Epigenetic and Immune Regulation
SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation.
Icariside II suppresses cervical cancer cell migration through JNK modulated matrix metalloproteinase-2/9 inhibition in vitro and in vivo.
Exogenous TIPE2 Inhibit TAK1 to Improve Inflammation and Neuropathic Pain Induced by Sciatic Nerve Injury Through Inactivating NF-κB and JNK.
Polysaccharides from Citrus grandis L. Osbeck suppress inflammation and relieve chronic pharyngitis.
Integrated miRNA and mRNA omics reveal dioscin suppresses migration and invasion via MEK/ERK and JNK signaling pathways in human endometrial carcinoma in vivo and in vitro